U.S. Water Utilities Stock News

NYSE:ZBH
NYSE:ZBHMedical Equipment

Is Zimmer Biomet (ZBH) Pricing Reflect Long Term Value After Multi Year Share Price Slide

Investors may be wondering whether Zimmer Biomet Holdings' current share price reflects its underlying value, or if the recent weakness has pushed it into potential opportunity territory. The stock closed at US$85.99, with a 0.9% decline over 7 days, a 5.3% decline over 30 days, a 4.5% decline year to date, and a 22.4% decline over the last year. It is 30.7% lower over 3 years and 41.7% lower over 5 years. Recent coverage of Zimmer Biomet has focused on its position in the medical devices...
NYSE:KMX
NYSE:KMXSpecialty Retail

Is CarMax (KMX) Offering Value After A 45.7% One Year Share Price Decline?

If you are wondering whether CarMax is attractively priced right now, this article will walk through what the numbers say about the stock and how that ties back to your expectations as an investor. CarMax shares last closed at US$46.34, with a 30 day return of 18.0%, a 7 day return of 2.3% decline, and a 1 year return of 45.7% decline, which may signal shifting views on both its potential and its risks. Recent coverage has focused on CarMax as a major player in the used car retail space,...
NYSE:GLW
NYSE:GLWElectronic

US Stock Market Today: S&P 500 Futures Edge Higher As Fed Decision And Tech Loom

The Morning Bull - US Market Morning Update Wednesday, Jan, 28 2026 US stock futures are pointing higher this morning, with S&P 500 contracts up around 0.3%, as investors focus on two big forces: the Federal Reserve and the health of the real economy. The Fed is expected to keep its key interest rate in a 3.5% to 3.75% range. This means borrowing costs for mortgages, credit cards and business loans stay where they are while investors listen closely for any hint on when the next cut might...
NYSE:HTGC
NYSE:HTGCCapital Markets

Hercules Capital Ties Savara Funding To FDA Milestone And Valuation Case

Hercules Capital (NYSE:HTGC) has amended its loan and security agreement with Savara Inc. The amendment gives Savara access to additional non dilutive capital if the FDA approves its lead therapy. The structure ties Hercules Capital's future funding to a key regulatory outcome for Savara. For Hercules Capital, a venture lending specialist with a focus that includes life sciences, this updated agreement deepens its role in biotech financing. Shares recently closed at $18.70, and the stock...